We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+60.24%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$455M
AUM Growth
+$76.5M
Cap. Flow
-$17.5M
Cap. Flow %
-3.84%
Top 10 Hldgs %
10.47%
Holding
364
New
134
Increased
50
Reduced
52
Closed
122

Sector Composition

Rank Sector Weight
1 Healthcare 32.59%
2 Technology 19.3%
3 Industrials 15.1%
4 Consumer Discretionary 13.8%
5 Financials 5.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDVT icon
51
Red Violet
RDVT
$979M
$2.63M 0.58%
141,877
+71,129
+101% +$1.15M
FLGT icon
52
Fulgent Genetics
FLGT
$470M
$2.54M 0.56%
196,737
+104,647
+114% +$1.24M
GBT
53
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.47M 0.54%
+31,085
New +$1.84M
AMED
54
DELISTED
Amedisys
AMED
$2.45M 0.54%
+14,660
New +$2.18M
IPHI
55
DELISTED
INPHI CORPORATION
IPHI
$2.42M 0.53%
32,666
+1,527
+5% +$105K
KOD icon
56
Kodiak Sciences
KOD
$2.6B
$2.41M 0.53%
33,534
-42,229
-56% -$1.54M
PCTI
57
DELISTED
PCTEL, Inc. Common Stock
PCTI
$2.4M 0.53%
283,744
+215,964
+319% +$1.79M
TRNS icon
58
Transcat
TRNS
$799M
$2.4M 0.53%
75,369
+39,090
+108% +$1.19M
CSW
59
CSW Industrials
CSW
$5.2B
$2.3M 0.51%
29,894
CNMD icon
60
CONMED
CNMD
$1.39B
$2.29M 0.5%
20,525
+944
+5% +$101K
RETA
61
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$2.29M 0.5%
11,228
+2,078
+23% +$379K
CHDN icon
62
Churchill Downs
CHDN
$5.88B
$2.27M 0.5%
33,126
-4,032
-11% -$263K
NWPX icon
63
NWPX Infrastructure Inc
NWPX
$1.19B
$2.25M 0.49%
67,552
+3,414
+5% +$108K
CSTL icon
64
Castle Biosciences
CSTL
$855M
$2.25M 0.49%
65,412
+31,407
+92% +$768K
CZR icon
65
Caesars Entertainment
CZR
$6.06B
$2.23M 0.49%
+37,323
New +$1.85M
THC icon
66
Tenet Healthcare
THC
$20.5B
$2.22M 0.49%
+58,404
New +$1.75M
ASC icon
67
Ardmore Shipping
ASC
$710M
$2.21M 0.49%
+244,540
New +$2.03M
INSP icon
68
Inspire Medical Systems
INSP
$1.45B
$2.19M 0.48%
29,582
-11,963
-29% -$769K
GNRC icon
69
Generac Holdings
GNRC
$11.6B
$2.19M 0.48%
21,806
-5,462
-20% -$508K
CROX icon
70
Crocs
CROX
$6.14B
$2.18M 0.48%
+51,963
New +$1.82M
ACAD icon
71
Acadia Pharmaceuticals
ACAD
$4.43B
$2.13M 0.47%
49,891
+2,329
+5% +$101K
FFIN icon
72
First Financial Bankshares
FFIN
$5.04B
$2.13M 0.47%
+60,684
New +$2.09M
SAH icon
73
Sonic Automotive
SAH
$2.9B
$2.09M 0.46%
67,320
-30,217
-31% -$956K
AXON
74
Axon Enterprise
AXON
$42.5B
$2.07M 0.46%
+28,271
New +$1.79M
NVRO
75
DELISTED
NEVRO CORP.
NVRO
$2M 0.44%
+17,055
New +$1.69M

Similar funds

EAM Investors's Q4 2019 Portfolio in Review

As of Q4 2019, EAM Investors held 364 positions worth $455M, up 20% from $378M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

EAM Investors withdrew a net $17.5M in Q4 2019, closing 122 positions and reducing 52 holdings. Its most notable exit was Magnite, an estimated $4.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.

Against the trend, EAM Investors opened a new position in Douglas Dynamics worth $3.94M.

  • EAM Investors's largest Q4 2019 buy was Douglas Dynamics: 71,630 shares worth $3.94M.
  • EAM Investors added most to BioDelivery Sciences International, Inc. in Q4 2019, an estimated $3.17M increase.
  • EAM Investors's biggest Q4 2019 reduction was Agilysys, cutting an estimated $3.21M.
  • EAM Investors fully exited Magnite in Q4 2019, selling an estimated $4.6M.
  • EAM Investors's ten largest holdings make up 10% of its $455M portfolio in Q4 2019.
  • EAM Investors opened 134 new positions and closed 122 in Q4 2019.
  • EAM Investors's portfolio value rose 20% quarter-over-quarter to $455M.

Based on EAM Investors's 13F filing for Q4 2019, filed 11 Feb 2020.